Texas Gov. Greg Abbott has signed into law a controversial "sanctuary cities" measure that allows police officers to ask people during routine stops if they are in the U.S. legally. Research analyst Pamela Cruz describes the legal fight to prevent the law's enforcement.
Drug Policy Program director Bill Martin summarizes the scientific and fiscal evidence supporting the efficacy of syringe exchange programs and outlines a framework for public policies to deal with this aspect of drug use and abuse.
During the 85th Legislative Session, Texas lawmakers have the opportunity to enact reforms to the current process by which the state selects its judges—in partisan elections in combination with a straight-ticket voting option. Political science fellow Mark P. Jones analyzes four reform options and their respective advantages and disadvantages.
Criminal extortion is on the rise in Mexico, particularly along the northern border states. Author Gary Hale shows how this trend has
fueled government corruption, with officials implicitly or explicitly aiding organized crime groups as they extort businesses and citizens.
This policy brief analyzes the impact of the increasing number of parents who opt their children out of school-entry vaccinations for nonmedical reasons in Texas and argues that the state should make obtaining nonmedical exemptions more rigorous in order to reduce the public health risks and costs associated with vaccine-preventable diseases.
Nonresident scholar Nathan P. Jones analyzes Joaquin "El Chapo" Guzman’s transfer to a Mexican prison near the Texas border and how it may impact his possible extradition and prosecution in the U.S.
This blog post examines four factors of globalization that make Texas a “ground zero” for new infectious tropical diseases and outlines steps the state must take to better mitigate global health threats.
Fellow Ed Egan examines the outlook for high-growth, high-technology entrepreneurship in Texas for a House committee on investment and financial services.
Just a decade ago, Texas’ venture capital investment was the third largest in the United States. Today, it has fallen to fourth and is set to slide to sixth, likely before 2016 is out.
This issue brief argues that continued investments in global health and the study of emerging pathogens could yield better tools to fight infectious diseases like the Zika virus long before they become a problem in the developed world.
Jennifer R. Herricks, Kirstin R.W. MatthewsMarch 4, 2016